ICOS Corporation

États‑Unis d’Amérique

 
Quantité totale PI 20
Rang # Quantité totale PI 74 153
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 468 401
Parent Eli Lilly and Company
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

8 0
2 4
6 0
0
 
Dernier brevet 2021 - Quinazolinones as inhibitors of ...
Premier brevet 1990 - Kinetic resolution of pyridazino...
Dernière marque 2005 - CHEF1
Première marque 1995 - ICOS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2020 Invention Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta. Compounds that inhibi...
2019 Invention Inhibitors of human phosphatidylinositol 3-kinase delta. Methods of inhibiting phosphatidylinosit...
Invention Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor ...
2016 Invention Inhibitors of human phosphatidylinositol 3-kinase delta. Methods of inhibiting phosphotidylinosi...
2015 Invention (s)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3h)-one precursor of a quinazolinone as inhib...
2013 Invention 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1...
Invention 6-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)-ethyl]-3h-quinazolin-4-one as an inhibitor of human p...
2012 Invention 6-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)ethyl]-3h-quinazolin-4-one as an inhibitor of human ph...
2010 Invention Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta. Compounds that inhibit...
2009 Invention Novel pi3k delta inhibitors and methods of use thereof. The present invention relates generally ...
Invention Modified pictet-spengler reaction and products prepared therefrom. A method of introducing a sec...
2008 Invention Inhibitors of human phosphatidyl-inositol 3-kinase delta. Compounds that inhibit PI3Kδ activity,...
Invention Inhibitors of human phosphatidyl-inositol 3-kinase delta. Compounds that inhibit PI3K.delta. acti...
Invention Inhibitors of human phosphatidyl-inositol 3-kinase delta. Compounds that inhibit PI3Kδ activity, ...
2007 Invention Thienopyrimidiones for treatment of inflammatory disorders and cancers. The current invention pr...
Invention Compositions of chk1 inhibitors and cyclodextrin. Compositions containing at least one Chk1 inhib...
Invention Compositions of chkl inhibitors and cyclodextrin. Compositions containing at least one Chk1 inhib...
Invention Compositions of chk1 inhibitors. Compositions containing at least one Chk1 inhibitor and at lease...
Invention Substituted phenyl acetic acids as dp-2 antagonists. Substituted phenyl acetic acid compounds of ...
Invention Substituted phenylacetic acids as dp-2 antagonists. Substituted phenyl acetic acid compounds of f...
Invention Recombinant method for making multimeric proteins. The present invention relates to methods for ...
2006 Invention Monoclonal antibodies recognizing human ccr8. The present invention generally relates to monoclon...
Invention Heteroaryl urea derivatives useful for inhibiting chk1. Substituted urea compounds useful in the ...
Invention Heteroaryl urea derivatives useful for inhibiting chk1. Substituted urea compounds of Formula II ...
Invention Heteroaryl urea derivatives useful for inhibiting chkl. Substituted urea compounds useful in the ...
Invention Novel human beta-2 integrin alpha subunit. Methods to inhibit inflammation and macrophage infilt...
Invention Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation. The invention relates...
2005 Invention Cgmp-binding, cgmp-specific phosphodiesterase materials and methods. The present invention provi...
Invention Compounds useful for inhibiting chk1. Aryl- and heteroaryl-substituted urea compounds useful in ...
P/S Nucleic acid sequences and biological reagents for medical and veterinary purposes, namely genes,...
Invention Compounds useful for inhibiting chk1. 3; Methods of making the compounds, and their use as therap...
P/S Development, processing and manufacturing of pharmaceuticals, therapeutics and biologics for others.
P/S Research and development relating to therapeutic and diagnostic products relating to human diseas...
Invention Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta. The invention provides...
Invention Arylphenylamino- and arylphenylether-sulfide derivatives, useful for the treatment of inflammator...
Invention Arylphenylamino-,arylphenylamide-, and arylphenylether-sulfide derivatives. The present inventi...
2004 Invention Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integr...
Invention Use of chk1 inhibitors to control cell proliferation. The present invention relates to improved ...
Invention Method of preparing a ring compound having two adjacent chiral centers. A method of synthesizing...
2003 Invention Cell-cycle checkpoint genes. This invention relates to a class of checkpoint genes and their pol...
2002 Invention Β-carboline pharmaceutical compositions. Formulations containing a PDE5 inhibitor, a water-solubl...
1995 P/S Therapeutics for the treatment of inflammatory diseases, namely: anti-inflammatories. Research an...